acs news/awards
Applications sought for 1998 ACS congressional fellows program Applications are being accepted for the fall 1998 ACS Congressional Fellowship Program. To date, 28 fellows have participated in the program, which began in 1974 and seeks to give fellows firsthand knowledge of the operation of the legislative branch, make scientific and technical expertise available to lawmakers, and forge links between the scientific and government communities. Applications are due no later than Jan. 1, 1998, for the term September 1998 to June 1999. The stipend for the fellowship program will be approximately $48,000 and includes a relocation allowance. Application materials for the program should include a résumé, two letters of reference, and a two-page letter of intent explaining candidates' reasons for applying, a description of their background in science and public policy, and details about what they would like to accomplish during the fellowship program. There are no specific requirements concerning academic degrees, but candidates should have "significant familiarity with a chemical science." Applications should be sent to Congressional Fellowship Program, ACS Office of Legislative & Government Affairs, 1155—16th St., N.W., Washington, D.C. 20036. For more information, contact Margaret A. Carey at the same address or phone (800) 2275558 ext. 4467.^
ACS Medicinal Chemistry Division awards predoctoral fellowships Five graduate students from around the U.S.—Michael Miller, Amy Ripka, Dylan Taatjes, Maria-Christina White, and Britta Wilmore—have been named recipients of the ACS Division of Medicinal Chemistry's 1997-98 Predoctoral Fellowships in Medicinal Chemistry. The recipients were chosen based on the type of research project each has pursued, the
quality of their research and level of research accomplishment, and their academic record and potential. Each student will receive a stipend of $20,000. Miller is a fourth-year student in the department of chemistry at the University of Memphis, where he is studying the synthesis of pyrimidoazepine analogs of folic acid as potential enzyme inhibitors of gly-
Medicinal chemistry predoctoral fellowship awardees are (clockwise from top left) Miller, Ripka, Taatjes, White, and Wilmore.
Knowing how iojjr 'Bayer organioel^daiabase'^disk, • equipment, the experience of mora than a hundred years andfinallya large team of highly qualified staff enable us to manufacture nearly 1,000 different organic chemicals and syntheses with maximum qualîy consistency, One example is:
4-Trifluoromethoxyaniline for use in the agrochemical and pharmaceutical industries. CIRCLE 19 ON READER SERVICE CARD
48 JULY 28, 1997 C&EN
Bayer AG Organic Chemicals Business Group Life Science Intermediates Business Unit D-51368 Leverkusen Fax: + 49 214/30 25 33 6 Bayer on the internet: http://www.bayer.com
Bayer
cinamide ribonucleotide formyltransferase and thymidylate synthase—potential antitumor agents. His fellowship is sponsored by Bristol-Meyers Squibb. Ripka is a fifth-year student in the department of medicinal chemistry at the University of Wisconsin, Madison. Her research is aimed at designing inhibitors for Rbizopus chinensis pepsin through the application of the structure-generating program entitled "GrowMol," and then synthesizing and testing these analogs. Her fellowship is sponsored by Abbott Laboratories. Taatjes is a fourth-year student in the department of chemistry at the University of Colorado, Boulder. He is studying the chemical processes associated with possible molecular mechanisms of interaction of adriamycin and daunomycin with DNA by examining the structure of adducts formed under oxidative conditions. His fellowship is sponsored by Wyeth-Ayerst Research. White is a fifth-year student in the department of chemistry at Baltimore's Johns Hopkins University. Her research is on the design and synthesis of novel analogs of la,25-dihydroxyvitamin D3 to aid in the structural requirements for hormonal activity. Her fellowship is sponsored by Parke-Davis. Wilmore is a fourth-year student in the department of medicinal chemistry at the University of Utah, Salt Lake City. Her thesis project is concerned with obtaining improved radioprotective agents and evaluating their effects in in vitro models for activity and toxicity. Her fellowship is sponsored by Hoechst Marion Roussel. Along with their stipends, fellowship recipients will receive a travel allowance from the Medicinal Chemistry Division to attend the 1998 fall ACS national meeting in Boston, where they will present their research results.^
Roche Award honors Stanford student Stanford University organic chemistry graduate student Chul Bom Lee has been awarded the Roche Award for Excellence in Organic Chemistry. Established last year by Hoffmann-La Roche and consisting of a certificate and $1,500, the award honors outstanding graduate students in organic chemistry in an effort to showcase the importance of that field in the pharmaceutical industry. Lee is a student of professor Barry M.
Trost at Stanford. He was cited for his work on catalytic asymmetric synthesis, a method for designing the three-dimensional structure of new organic compounds. Three-dimensional structure determines the biological action of many natural substances and therapeutic agents. In addition, Lee's research interests include designing effective and environmentally safe methods for synthesizing new compounds. After receiving a Ph.D. degree, he would like to begin a research program at an academic institution— where he can also teach—in the area of organic synthesis.^
Kaminsky receives Carothers Lecture Award Walter Kaminsky, professor of technical and macromolecular chemistry at the University of Hamburg, Germany, has received the 1997 Carothers Lecture Award of the ACS Delaware Section. The award, which consists of $1,000 and a sculpture, honors innovators who have made out-
standing contributions and advances in industrial applications of chemistry. The award is sponsored by the Delaware Section, DuPont, Hercules, Zeneca, DuPont Merck, and Montell. This year, the award is cosponsored by DuPont Dow Elastomers and by Mobil Technology Co. In particular, Kaminsky is cited for his pioneering work in catalysis and in the recycling of plastics. He invented the socalled Kaminsky catalyst, using methylalumoxane-activated metallocenes, which has stimulated vigorous worldwide research activity in metallocene catalysts. Later, his seminal work on chiral catalysts extended the technology to isotactic polypropylene. Many of these polymers are in the process of being commercialized. In addition, he has discovered processes to recycle plastics, and a pilot plant based on his technology is currently operating in Europe. Kaminsky received a Ph.D. degree in chemistry from Hamburg in 1971; he became an assistant professor there in 1977 and a full professor in 1979. He has published more than 200 scientific papers and books and holds 12 patents.^
Better Solutions The ACS National Meeting is w h e r e you'll discover the latest a d v a n c e m e n t s that are shaping your future.
For meeting, registration and housing information visit us on t h e Internet:
www.acs.org/meetings/Iasvegas The 214th National Meeting and Exposition, September 7-11, 1997, in Las Vegas, Nevada, is hosted by the American Chemical Society.
JULY 28, 1997 C&EN 49
